Cargando…
Haemoglobin Mass and Running Time Trial Performance after Recombinant Human Erythropoietin Administration in Trained Men
Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hb(mass)) and maximal oxygen uptake ([Image: see text] O(2 max)). PURPOSE: This study defined the time course of changes in Hb(mass), [Image: see text] O(2 max) as well as running time trial performance following 4 weeks of rHuEpo...
Autores principales: | Durussel, Jérôme, Daskalaki, Evangelia, Anderson, Martin, Chatterji, Tushar, Wondimu, Diresibachew H., Padmanabhan, Neal, Patel, Rajan K., McClure, John D., Pitsiladis, Yannis P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571963/ https://www.ncbi.nlm.nih.gov/pubmed/23418527 http://dx.doi.org/10.1371/journal.pone.0056151 |
Ejemplares similares
-
Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
por: Wang, Guan, et al.
Publicado: (2017) -
Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin
por: Wang, Guan, et al.
Publicado: (2021) -
The Modifications of Haemoglobin, Erythropoietin Values and Running Performance While Training at Mountain vs. Hilltop vs. Seaside
por: Man, Maria Cristina, et al.
Publicado: (2021) -
A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin
por: Oskarsson, Gudjon R., et al.
Publicado: (2018) -
Interpretation of Erythropoietin and Haemoglobin Levels in Patients with Various Stages of Chronic Kidney Disease
por: Panjeta, Mirsad, et al.
Publicado: (2017)